BusinessGeneral NewsIndustryInternationalUncategorized

Global Thyroid Cancer Drug Market Demand Analysis & Opportunity Evaluation || Top Growing Companies – Jerome Stevens Pharmaceuticals, Inc, Baxter, Abbott

To uncover the general market conditions and tendencies, Thyroid Cancer Drug Market research report acts as a perfect source. This report helps in planning by providing precise and state-of-the-art information about the consumer’s demands, preferences, attitudes and their changing tastes about the specific product. The Thyroid Cancer Drug Market report is a window to the Pharmaceutical industry which explains what market definition, classifications, applications, engagements and market trends are. The numerical data of this report is mainly backed up by two statistical tools such as SWOT analysis and Porter’s Five Forces Analysis. The Thyroid Cancer Drug Market report plays key role in keeping hold of reputation of the firm and its products. Thyroid Cancer Drug Market research report also directs the manufacturer about planning of advertising and sales promotion efforts and makes it more effective.

Thyroid cancer is also known as thyroid nodules is a cancer occur in thyroid gland and can spread to other parts of the body and about 90% of all thyroid cancers are benign. According to the statistics published in American Cancer Society 2019, it is estimated that 52,070 patients to be diagnosed with thyroid cancer in the United States in this current year. It is more prevalent in women and near 2% of cases occurs in children. Growing population of thyroid cancer and adopting unhealthy life style are the key factors for market growth.

Global thyroid cancer drug market is rise gradually to an estimated value of USD 2404.8 million by 2026 registering a CAGR of 24.3% in the forecast period of 2019-2026. Increasing prevalence of thyroid cancer and accelerating demand of clinical treatment and novel therapies indicates the significant growth of market.

Get Sample Analysis of Global Market Information:

Few of the major competitors currently working in the thyroid cancer drug market are Mylan N.V., Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd, Jerome Stevens Pharmaceuticals, Inc, Baxter, Abbott, Celgene Corporation, AstraZeneca, GlaxoSmithKline plc, Eisai Co., Ltd, Takeda Pharmaceutical Company Ltd, Biovista, Cytori Therapeutics Inc, Bayer AG, Novartis AG, Bio-Path Holdings, Inc, Vascular Biogenics, and few among others.

Market Drivers

  • Increase in prevalence rate of neuroendocrine tumor worldwide
  • Accelerating demand of treatment and novel therapies
  • Rising awareness about treatment and technological advancement is driving the growth of market
  • Increases cases of obesity and adopting unhealthy life style

Market Restraints

  • Effective treatment is either unavailable or unaffordable
  • Patent expiry of the patented drugs and introduction of generic version of branded drugs is expected to restrain the growth if the market
  • Inadequate awareness about thyroid cancer treatment in some developing countries

Segmentation: Global Thyroid Cancer Drug Market

By Type

  • Papillary thyroid cancer
  • Follicular thyroid cancer
  • Hurthle cell cancer
  • Medullary thyroid cancer (MTC)
  • Anaplastic thyroid cancer

By Drug Type

  • Thyroid desiccated
  • Sorafenib
  • Thyrotropin alfa
  • Vandetanib
  • Doxorubicin
  • Cabozantinib
  • Lenvatinib
  • Sodium iodide I-131
  • Dabrafenib
  • Trametinib
  • Others

By Treatment

  • Medication
  • Chemotherapy
  • Radioactive iodine (radioiodine) therapy
  • Hormone therapy
  • Surgery
    • Lobectomy
    • Near-total thyroidectomy
    • Total thyroidectomy

By Route of administration

  • Oral
  • Injectable
  • Others

By End users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Turkey
    • Belgium
    • Netherlands
    • Switzerland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • South Korea
    • India
    • Australia
    • Singapore
    • Thailand
    • Malaysia
    • Indonesia
    • Philippines
    • Rest of Asia Pacific
  • Middle East & Africa
    • South Africa
    • Egypt
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Rest of Middle East & Africa

Get TOC of Full Report:

Key Developments in the Market:

  • In May 2018, Novartis AG received FDA approval for Tafinlar in combination with Mekinist (trametinib) for the treatment of anaplastic thyroid cancer comprising of abnormal gene known as BRAF V600E
  • In March 2018, Eisai Co., Ltd and Merck & Co., Inc entered into research collaboration for exclusive worldwide co-development and co- commercialization of Lenvima in combination with pembrolizumab for 11 potential indications in six types of cancer (endometrial cancer, non-small cell lung cancer, hepatocellular carcinoma, head and neck cancer, bladder cancer and melanoma). Lenvima has been approved from the FDA for the treatment of differentiated thyroid cancer

Competitive Analysis: Global Thyroid Cancer Drug Market

Global thyroid cancer drug market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of thyroid cancer drug market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Research Methodology: Global Thyroid Cancer Drug Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call or can drop down your inquiry.

The key research methodology used by . team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global thyroid cancer drug market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

To Know More :

About Us

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing [email protected] . We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475
Mail: [email protected]

Report Rating